Company / Capital Expenditures
IQVIA Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$603.0M
FY2025
5-year range
$582.0M / $649.0M
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#17 of 151
Health Care
What the data says
IQVIA's capital expenditures of $603M is higher than 89% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $164M in FY2018 to $649M in FY2023.
Based on SEC 10-K filings.
$603M in FY2025 with a 5-year CAGR of +5.6%. Top quartile in the Health Care sector.
Declined from $649M to $603M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -0.7%
- 5-Year CAGR
- +5.6%
- 10-Year CAGR
- -
Sector benchmark
+122.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +5.6%, indicating consistent growth.
- In FY2025, capital expenditures increased 0.2% year-over-year.
- Ranks #17 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 20.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $603.0M | +0.2% |
| FY2024 | $602.0M | -7.2% |
| FY2023 | $649.0M | +5.4% |
| FY2022 | $616.0M | +5.8% |
| FY2021 | $582.0M | +26.8% |
| FY2020 | $459.0M | +24.4% |
| FY2019 | $369.0M | +125.0% |
| FY2018 | $164.0M | -55.6% |
| FY2017 | $369.0M | +125.0% |
| FY2016 | $164.0M | +110.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026